Deutsche Bank’s Cocrystal Pharma COCP Stock Holding History

Deutsche Bank’s Portfolio COCP Stock Details COCP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-466	Closed	-$2K	–	4396
2019 Q4	$2K	Buy	+466	New	+$4.65K	﹤0.01%	4815

Other funds holding COCP

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Emory University Atlanta, Georgia $267M AUM 48.26% 1-Year Est. Return

Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return

Deutsche Bank's COCP Position: Q1 2020 in Review

Deutsche Bank sold out of Cocrystal Pharma (COCP) in Q1 2020, closing a stake of 466 shares — an estimated $2K sold.

Deutsche Bank first reported a position in COCP in Q4 2019 and held it in 1 quarter. The position peaked at $2K in Q4 2019. 24 funds tracked by Wall St. Rank hold COCP as of Q1 2020.

Deutsche Bank reported no remaining Cocrystal Pharma position as of Q1 2020 after selling out during the quarter.
Deutsche Bank sold 466 Cocrystal Pharma shares in Q1 2020, an estimated $2K.
Deutsche Bank first reported a position in Cocrystal Pharma in Q4 2019 and held it in 1 quarter.
Deutsche Bank's Cocrystal Pharma position peaked at $2K in Q4 2019.
24 funds tracked by Wall St. Rank held Cocrystal Pharma as of Q1 2020.

Based on Deutsche Bank's 13F filing for Q1 2020, filed 14 May 2020.